Company Filing History:
Years Active: 2022-2023
Title: Grazia Maria Letizia Consoli: Innovator in Ocular Disease Treatments
Introduction
Grazia Maria Letizia Consoli is a prominent inventor based in San Gregorio di Catania, Italy. She has made significant contributions to the field of ocular disease treatments through her innovative research and patented formulations. With a total of three patents to her name, Consoli is recognized for her work in developing advanced delivery systems for active ingredients.
Latest Patents
Consoli's latest patents focus on nanostructured formulations designed for the delivery of silibinin and other active ingredients aimed at treating ocular diseases. These formulations incorporate silibinin or other active ingredients within lipid nanoparticle systems of the SLN and NLC type. They are based on calixarenes, which may be mucoadhesive, or in micellar and nanoparticle systems utilizing amphiphilic inulin copolymers. The versatility of the calixarene compound is highlighted, as it can charge and release active ingredients that are characterized by low water solubility, easy chemical and enzymatic degradation, and low bioavailability. This innovation is particularly beneficial for treating neurodegenerative ocular diseases.
Career Highlights
Consoli is affiliated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where she continues to advance her research in nanotechnology and its applications in medicine. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from ocular diseases.
Collaborations
Throughout her career, Consoli has collaborated with notable colleagues, including Anna Rita Blanco and Gennara Cavallaro. These partnerships have contributed to the development and refinement of her innovative formulations.
Conclusion
Grazia Maria Letizia Consoli stands out as a leading inventor in the field of ocular disease treatments. Her groundbreaking work in nanostructured formulations showcases her commitment to advancing medical science and improving patient care.